These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 9250421)
1. The role of beta-glucuronidase in drug disposition and drug targeting in humans. Sperker B; Backman JT; Kroemer HK Clin Pharmacokinet; 1997 Jul; 33(1):18-31. PubMed ID: 9250421 [TBL] [Abstract][Full Text] [Related]
2. Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: comparison with the corresponding antibody-enzyme conjugate. Fonseca MJ; Jagtenberg JC; Haisma HJ; Storm G Pharm Res; 2003 Mar; 20(3):423-8. PubMed ID: 12669963 [TBL] [Abstract][Full Text] [Related]
3. Expression of active human beta-glucuronidase in Sf9 cells infected with recombinant baculovirus. Sperker B; Mürdter TE; Backman JT; Fritz P; Kroemer HK Life Sci; 2002 Aug; 71(13):1547-57. PubMed ID: 12127909 [TBL] [Abstract][Full Text] [Related]
4. Interindividual variability in expression and activity of human beta-glucuronidase in liver and kidney: consequences for drug metabolism. Sperker B; Mürdter TE; Schick M; Eckhardt K; Bosslet K; Kroemer HK J Pharmacol Exp Ther; 1997 May; 281(2):914-20. PubMed ID: 9152401 [TBL] [Abstract][Full Text] [Related]
5. Selective cancer therapy by extracellular activation of a highly potent glycosidic duocarmycin analogue. Chen KC; Schmuck K; Tietze LF; Roffler SR Mol Pharm; 2013 May; 10(5):1773-82. PubMed ID: 23448264 [TBL] [Abstract][Full Text] [Related]
6. Beta-glucuronidase-mediated drug release. de Graaf M; Boven E; Scheeren HW; Haisma HJ; Pinedo HM Curr Pharm Des; 2002; 8(15):1391-403. PubMed ID: 12052215 [TBL] [Abstract][Full Text] [Related]
7. A humanized immunoenzyme with enhanced activity for glucuronide prodrug activation in the tumor microenvironment. Chen KC; Wu SY; Leu YL; Prijovich ZM; Chen BM; Wang HE; Cheng TL; Roffler SR Bioconjug Chem; 2011 May; 22(5):938-48. PubMed ID: 21443266 [TBL] [Abstract][Full Text] [Related]
8. Expression and function of beta-glucuronidase in pancreatic cancer: potential role in drug targeting. Sperker B; Werner U; Mürdter TE; Tekkaya C; Fritz P; Wacke R; Adam U; Gerken M; Drewelow B; Kroemer HK Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):110-5. PubMed ID: 10961372 [TBL] [Abstract][Full Text] [Related]
9. Deconjugation of N-glucuronide conjugated metabolites with hydrazine hydrate--biomarkers for exposure to the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Frandsen H Food Chem Toxicol; 2007 May; 45(5):863-70. PubMed ID: 17184892 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of self-immolative glucuronide-based prodrugs of a phenol mustard. Lougerstay-Madec R; Florent JC; Monneret C; Nemati F; Poupon MF Anticancer Drug Des; 1998 Dec; 13(8):995-1007. PubMed ID: 10335272 [TBL] [Abstract][Full Text] [Related]
11. Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy. Wang SM; Chern JW; Yeh MY; Ng JC; Tung E; Roffler SR Cancer Res; 1992 Aug; 52(16):4484-91. PubMed ID: 1643640 [TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery. Haeberlin B; Rubas W; Nolen HW; Friend DR Pharm Res; 1993 Nov; 10(11):1553-62. PubMed ID: 8290467 [TBL] [Abstract][Full Text] [Related]
14. Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes. Chen KC; Cheng TL; Leu YL; Prijovich ZM; Chuang CH; Chen BM; Roffler SR Cancer Gene Ther; 2007 Feb; 14(2):187-200. PubMed ID: 16977328 [TBL] [Abstract][Full Text] [Related]
15. Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy. Florent JC; Dong X; Gaudel G; Mitaku S; Monneret C; Gesson JP; Jacquesy JC; Mondon M; Renoux B; Andrianomenjanahary S; Michel S; Koch M; Tillequin F; Gerken M; Czech J; Straub R; Bosslet K J Med Chem; 1998 Sep; 41(19):3572-81. PubMed ID: 9733483 [TBL] [Abstract][Full Text] [Related]
16. Conjugation-deconjugation cycling of diflunisal via beta-glucuronidase catalyzed hydrolysis of its acyl glucuronide in the rat. Brunelle FM; Verbeeck RK Life Sci; 1997; 60(22):2013-21. PubMed ID: 9180355 [TBL] [Abstract][Full Text] [Related]
17. On-line deconjugation of glucuronides using an immobilized enzyme reactor based upon beta-glucuronidase. Di Marco MP; Felix G; Descorps V; Ducharme MP; Wainer IW J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(2):379-86. PubMed ID: 9792524 [TBL] [Abstract][Full Text] [Related]
18. Expression of β-glucuronidase on the surface of bacteria enhances activation of glucuronide prodrugs. Cheng CM; Chen FM; Lu YL; Tzou SC; Wang JY; Kao CH; Liao KW; Cheng TC; Chuang CH; Chen BM; Roffler S; Cheng TL Cancer Gene Ther; 2013 May; 20(5):276-81. PubMed ID: 23598434 [TBL] [Abstract][Full Text] [Related]
19. Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site. Mürdter TE; Sperker B; Kivistö KT; McClellan M; Fritz P; Friedel G; Linder A; Bosslet K; Toomes H; Dierkesmann R; Kroemer HK Cancer Res; 1997 Jun; 57(12):2440-5. PubMed ID: 9192823 [TBL] [Abstract][Full Text] [Related]
20. Human and Escherichia coli beta-glucuronidase hydrolysis of glucuronide conjugates of benzidine and 4-aminobiphenyl, and their hydroxy metabolites. Zenser TV; Lakshmi VM; Davis BB Drug Metab Dispos; 1999 Sep; 27(9):1064-7. PubMed ID: 10460807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]